When logistic regression models were run separately in diabetic and non-diabetic subjects, a statistically significant doubling of odds of CKD among those with high pentraxin-3 was observed in non-diabetic subjects, while a much larger but not statistically significant increase in odds of CKD was observed among diabetic subjects. Here, PTX3 is linked to chronic kidney disease.